SUMMARY -Primary premature ovarian insuffi ciency (PPOI) is characterized by hypergonadotropic amenorrhea and hypoestrogenism in women under 40 years of age. PPOI incidence is 1:10,000 in women aged 18-25, 1:1000 in women aged 25-30 and 1:100 in women aged 35-40. In 10%-28% of cases, PPOI causes primary and in 4%-18% secondary amenorrhea. Th e process is a consequence of accelerated oocyte atresia, diminished number of germinated cells, and central nervous system aging. Specifi c genes are responsible for the control of oocyte number undergoing the ovulation process and the time to cessation of the reproductive function. A positive family history of PPOI is found in 15% of women with PPOI, indicating the existing genetic etiology. Primary POI comprises genetic aberrations linked to chromosome X (monosomy, trisomy, translocation, deletion) or to autosomal chromosome. Secondary POI implies surgical removal of ovaries, chemotherapy and radiotherapy, and infections. Diagnostic criteria include follicle stimulating hormone level >40 IU/L and estradiol level <50 pmol/L.
Introduction
Premature ovarian insuffi ciency (POI) is characterized by hypergonadotropic amenorrhea and hypoestrogenism in women under 40 years of age. Diagnostic criteria are follicle stimulating hormone (FSH) level >40 IU/L and estradiol (E2) level <50 pmol/L 1 . Th e POI incidence is 1:10,000 in women aged 18-25, 1:1000 in women aged 25-30 and 1:100 in women aged 35-40 2 . POI causes 10%-28% of primary amenorrhea and 4%-18% of secondary amenorrhea 3 . Th e onset of the disease is a consequence of an accelerated process of oocyte atresia, i.e. a diminished number of germinated cells, and maturation of the central nervous system. Specifi c genes are responsible for the control of oocyte number undergoing ovulation process and cessation of the reproductive period 4 . A positive family history of POI was found in 15% of women with POI, confi rming the existing genetic etiology 5, 6 . Before the 20 th week of gestation, the meiosis and mitosis processes go in parallel in the ovary and after that time, maturation and distribution of the future oocytes is completed. Th e number of oocytes is limited at birth; therefore, there will be no further production of this cell type. Th e maximum number of primordial follicles in the female fetus increases in 20-24 weeks of gestation, when the process of atresia starts. In the process of cessation, the number of primordial follicles decreases from 6-7 million to 1-2 million at birth, then to 300,000-400,000 on entering puberty. Th e ongoing process of steroidogenesis takes place up to the last follicle exists. It is well known that typical climacteric symptoms start when the number of primordial folli-cles decreases below 2500 in both ovaries. Th e increase in FSH starts shortly after age 30, while the number of the rest of the follicles correlates with further FSH increase after age 40. Diff erence between the primordial and primary follicles is determined by layers of granulosa cells surrounding oocytes, with one layer in primordial follicles and multiple layers of cuboid granulosa cells in primary follicles. One of the possible etiologic factors for primary POI might be a disorder at the level of transmission from primordial to primary follicles.
Every woman younger than 40 with amenorrheic period is obliged to seek help at the gynecologist offi ce. Symptoms of POI are psychological (nervousness, hot fl ushes, excitability, insomnia, depression, loss of libido, lack of concentration) and physical (parts of body feeling numb or tingling, muscle or joint pains, body weight increase). Hormone analysis (FSH, luteinizing hormone (LH), estradiol (E2), antimüllerian hormone (AMH), inhibin B, prolactin, progesterone, testosterone, free thyroxine (fT4) and thyroid-stimulating hormone (TSH)) is necessary. POI diagnosis is confi rmed by FSH >40 IU/L and estradiol <50 pmol/L in women aged <40. When Addison's disease is suspected, adrenocorticotopic hormone (ACTH) stimulation test is performed. Karyotyping is necessary in women younger than 30. Ovarian biopsy is not a routine procedure. Dual energy x-ray absorptiometry is recommended in screening for osteoporosis.
Etiology
Premature ovarian insuffi ciency is divided into two main groups: primary POI (PPOI) and secondary POI (SPOI). Th e etiology of PPOI is shown in Table 1 .
Genetic Causes

Follicle-stimulating hormone receptor gene mutation
In some families, familial PPOI occurrence is fi gured out (grandmother, mother and daughter) earlier in every consecutive generation. One of the possible causes is a mutation in the FSH receptor gene. Inactivated mutation of the FSH receptor (FSHR) gene damages adenylyl cyclase stimulation, while the receptor remains captured inside the cell. FSH is essential for normal follicle maturation. In the last 50 days of its development, maturation of the follicle is blocked. A large number of small follicles with no ability to progress further are present in women with PPOI. Th e most frequent mutation is present in exon 7 of the FSHR gene (FSHR, located on 2p chromosome), replacing Ala to Val at protein level. Mutations of the FSHR gene are related to FSH resistance, which leads to an increased FSH level and a decreased estrogen serum level. Women with total FSH resistance have hypoplastic ovaries and primary amenorrhea 7 . Some other forms of FSHR have been identifi ed in women with PPOI and secondary amenorrhea, moderate ovary dysfunction and family history of PPOI 8 . Th ese variances are rare and there is no direct infl uence in the etiology of PPOI 9, 10 .
Structural alterations of chromosome
X chromosome alterations are the most frequent genetic causes of PPOI, accounting for 12% of cases 6, [11] [12] [13] . Th ese alterations comprise complete monosomy or partial deletion, duplication or translocation of the X chromosome, as follows: a) Turner syndrome (45X0) -the prevalence of X monosomy is 1:2500. Turner syndrome is characterized by lower height than normal, gonadal dysgenesis and primary amenorrhea 14 . Oocyte deprivation begins mainly in the early childhood as a consequence of accelerated follicle atresia 14 . b) Trisomy X (47 XXX) -usually does not cause particular problems, but in some cases PPOI 15 . Th e genes located on the X chromosome are critical for the normal function of the ovary, thus any abnormality can induce PPOI 9, 16 . Groswani et al. 17 found that 3.8% of women with PPOI had X chromosome trisomy. c) Fragile X chromosome -expansion of trinucleotide tandem repeat CGG at the 5'UTR region of the FMR 1 gene (Xq27.3) was found in some PPOI cases. Th e CGG tandem repeat variation length is defi ned as normal (≤50), premutation and full mutation (≥200 tandem repeats). Full mutation is associated with a fragile X syndrome, where mental retardation is the crucial sign 18 . Recently, some epidemiological studies have found connection of the premutation FMR1 gene with PPOI in 6% of sporadic cases and 13% of family PPOI 19 . FMR1 protein is expressed in fetal germ cells, as well as in granulosa cells of the mature follicle 20 . Th e carriers of the premutation alleles can exhibit 3 clinical forms, i.e. PPOI; lack of concentration/attention and other psychological changes; and neurologic disorders (tremor, ataxia, Parkinson's disease).
Hegerman et al. 21 indicated the association of PPOI with tremor, ataxia and Parkinson's disease, which could be one more proof of the important role of sex steroids in the brain.
In the most prominent number of cases, PPOI seems to be a multifactorial disorder. From this point of view, studies of the gene-DNA polymorphism are crucial in clarifying PPOI etiology. DNA or gene polymorphisms express the variants in hereditary basis, which could be found in the general population. From the phenotype point of view, they are in principle 'benign', but could also represent predisposition for certain, usually multifactorial disorders 22 . Polymorphisms in the genes encoding steroid hormone receptors, as well as their connection with diff erent reproductive system disorders have been intensively studied in the last few years. It is well known that the forehand expression and proper coordination of the genes are fundamental for the normal growth and development of the ovary 23 . Polymorphisms important for PPOI are mostly unknown despite of the pathogenic defects identifi ed in some candidate genes 24, 25 . Th erefore, in most PPOI cases, no clear etiologic factors were found, so they were classifi ed as idiopathic PPOI.
Oocyte-specifi c transcription factors
In homozygous FOXL2 mutation, granulosa cells do not undergo transition from squamous to cuboid, and it is exactly the layer where the mistake comes from. Th is is the reason for the absence of secondary follicles, so oocyte atresia occurs 26 . Th e genes specifically expressed in oocyte are regulated through the specifi c transcription factors 12 . Mutations are identifi ed in several genes encoding transcriptional factors important for folliculogenesis, i.e. NRA1, NOBOX, FIGLA and FOXL2 [27] [28] [29] . Nuclear Receptor subfamily fi fth group term 1 (NR5A1), known as steroidogenic factor 1, is a nuclear receptor which is implicated in early gonadal diff erentiation 29, 30 . Th e NR5A1 gene is located at 9q33.3. Steroidogenesis is modulated through the regulation of the genes involved in the hypothalamic-pituitary--steroidogenetic axis, such as: STAR, CYP11A1, CYP17A1, CYP19A1, LH and INHA 30 . Homeobox protein (NOBOX) -the newborn ovary homeobox gene is an oocyte -is a specifi c expressed gene with an essential role in folliculogenesis and so one of the candidate genes for PPOI 28 . It is responsible for the specifi c transcriptional factor which regulates the genes important for early folliculogenesis 31 . Using the knockout mouse model, it has been proven that NOBOX regulates diff erent gene expressions specifi c for the oocyte, including BMP-15 and GDF-9 31 . Th e lack of NOBOX expression is connected with accelerated oocyte loss after mouse parturition 30 . Folliculogenesis Specifi c Basic Helix-Loop-Helix (FIGLA), the embryo-specifi c transcription factor, regulates expression of the genes responsible for the initiation of folliculogenesis and coding the zona pellucida proteins (ZP1, ZP2 and ZP3) essential for fecundation and embryo survival. It is crucial for oocyte rebellion and formatting the primordial follicles 32 . Its lack leads to accelerated loss of postnatal primordial follicles in mice 33 . Forkhead Box L2 (FOXL2) gene is located on 3q23. Foxl2 protein exudes in the granulosa cells from the embryogenesis until the adult age 27 . Th e mutation of this gene leads to failure of granulosa cell diff erentiation, which induces early activation and exhaustion of primordial follicles 33 . Th e FOXL2 mutation is identifi ed in 5% of non-syndromic PPOI patients, suggesting the possibility of idiopathic PPOI occurrence 27 .
Helix-loop-helix (SOHLH) 1 and 2 are transcription factors important for PPOI. Th ey are responsible for the follicle early growth and diff erentiation by control of a number of genes including NOBOX, FIGLA, BMP-15 and GDF-9 12 . Th e SOHLH2 gene is located on chromosome 13. Th is gene codes one of the factors which are crucial for spermatogenesis, oogenesis and folliculogenesis 12 . Zhao et al. 34 found three new SOHLH1 variations as the potential cause of PPOI in 364 Chinese women with PPOI.
Folliculogenesis growth factors
Bone morphogenetic protein 15 (BMI-15) is a member of the transforming growth factor ß (TGF-ß) superfamily. Th e gene is located at Xq11.2 and encodes an oocyte-specifi c growth and diff erentiation factor 35 . BMP-15 is involved in stimulating folliculogenesis and promoting follicle maturation by regulating granulosa cell diff erentiation and proliferation 36 . Th e growth diff erentiation factor 9 (GDF9) gene, a homologue of BMP-15, is also member of the TGF-ß superfamily and is located at 5q23.2. Like BMP-15, GDF-9 is oocyte specifi c and regulates primordial follicle development and stimulates granulosa cell proliferation and follicle maturation 30 . GDF-9 is also thought to play a role in steroidogenesis and modulation of FSH sensitivity in granulosa cell 37 . Inhibin alpha (INHA) gene encodes the alpha subunit of inhibin A and inhibin B, which together with their corresponding beta units (INHBA and INHBB) , a class of dimeric glycoproteins, also belong to the TGF-ß superfamily 38 . Inhibins are produced primarily by granulosa cells and act on the pituitary by inhibiting FSH production 39 . Decreased inhibin production is associated with increased FSH production, leading to enhanced follicle recruitment and increased depletion of the follicular pool 11 . Indeed, women with idiopathic POI have lower serum levels of inhibins and higher serum FSH as compared with age-matched fertile controls, suggesting that inhibins play an important role in normal ovarian function 39 . Some of the gene candidates and their function in the pathogenesis of PPOI are shown in Table 2 40 .
Receptors
Estrogen receptors
Estrogen receptors (ER) are transcriptional factors that occur in granulosa cells, as well as in many other tissues and are involved in the expression of diff erent genes included in the cell growth and development 41 . Th ere are two estrogen receptors known as ERa and ERb. Estrogen regulates gonadotropin release via ERa action, labeled with ESR1 on the hypothalamic-hypophyseal axis 42 . Th e ERa gene is located on 6q25-27 chromosome. Its promoter area comprises a polymorphic chain TA tandem repeat, associated with hereditary premature ovarian dysfunction, as well as with diminished bone mineral density and endometriosis.
Th e ERb gene is located on the 14q23-24 chromosome. Estrogen improves folliculogenesis via ERb 42 . On uncoding 3'-region of this gene, a polymorphic CA tandem repeat chain was recently identifi ed, speculating about its connection with bone mineral density in women 43 . Th e functional role of these two polymorphisms has not yet been fully clarifi ed; however, there is some evidence for their infl uence on the structure and function of the genes 44 . Th e connection between 45, 46 .
Progesterone receptor
Th e progesterone receptor (PGR) gene is situated on the 11q22 chromosome. A number of polymorphic regions have been discovered in this gene, and one of the functionally most important is the insertion/deletion of ALu sequence of 306 bp. It is believed that the insertion allele, labeled as PROGINS, has a protective function in the female reproductive system, either in the homozygous or heterozygous state 47 .
Androgen receptor
Androgen receptor (AR) belongs to the nuclear transcriptional factors family. Th e only AR gene is located on chromosome X, Xq11-12. In this gene, polymorphism of a diff erent number of CAG tandem repeats encoding the polyglutaminic chain of diff erent lengths, has been identifi ed. Th is chain infl uences the receptor function, so that longer tandem repeats are connected with a lower functional level of the receptor 48 . In fact, in the fi rst exon of the AR gene, there are 2 microsatellite polymorphisms; the fi rst one with CAG tandem repeats -(CAG)n and the second one with GGN tandem repeats -(GGN)n. A limited number of studies have found correlation of CAG repetitions in AR gene and PPOI 49, 50 , while others did not confi rm this correlation 46, 51 . For the GGN tandem repeat in Indian women, a signifi cant correlation with PPOI has been reported 51 .
Enzyme Defi ciency
One of the etiologic factors for PPOI is defi ciency of 17-a hydroxylase (17OH), as well as galactose-1-phosphate uridyltransferase (GALT). According the study by Waggoner et al., shortly after puberty, 81% of aff ected women develop ovarian insuffi ciency together with primary or secondary amenorrhea 52 . Typical characteristics of women with the lack of 17OH are primary amenorrhea, high levels of FSH, LH, progesterone, deoxycorticosterone, hypertension and hyperpotassium alkalosis. Intracellular accumulation of galactose metabolite or lacking glycosylation decreases germ cell reserve 53 .
Conclusion
Today, PPOI is considered as a multifactorial disease, where the phenotype is most probably the result of sequence variation in more than one gene. Ethnically distinct populations show diff erences in the generegulating pathways and genes causing PPOI.
